A Novel Device for Islet Transplantation Providing Immune Protection and Oxygen Supply

Abstract

Islet transplantation as a biological β-cell replacement therapy has emerged as a promising option for achieving restoration of metabolic control in type 1 diabetes patients. However, partial or complete loss of islet graft function occurs in relatively short time (months to few years) after implantation. The high rate of early transplant dysfunction has been attributed to poorly viable and/or functional islets and is mediated by innate inflammatory response at the intravascular (hepatic) transplant site and critical lack of initial nutrient/oxygen supply prior to islet engraftment. In addition, the diabetogenic effect of mandatory immunosuppressive agents, limited control of alloimmunity, and the recurrence of autoimmunity limit the long-term success of islet transplantation. In order to abrogate instant blood-mediated inflammatory reaction and to provide oxygen supply for the islet graft, we have developed an extravascular (subcutaneous) transplant macrochamber (the ‘βAir’ device). This device contains islets immobilized in alginate, protected from the immune system by a thin hydrophilized teflon membrane impregnated with alginate and supplied with oxygen by daily refueling with oxygen-CO₂ mixture. We have demonstrated successful utilization of the oxygen-refueling macrochamber for sustained islet viability and function as well as immunoprotection after allogeneic subcutaneous transplantation in healthy minipigs. Considering the current limitations of intraportal islet engraftment and the restricted indication for islet transplantation mainly due to necessary immunosuppressive therapy, this work could very likely lead to remarkable improvements in the procedure and moreover opens up further strategies for porcine islet cell xenotransplantation.

Key words

diabetes - new device - islet transplantation - encapsulation

References

• 1 Steffes MW, Sibley S, Jackson M, Thomas W. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.  Diabetes Care. 2003;  26 832-836
• 2 White SA, Shaw JA, Sutherland DE. Pancreas transplantation.  Lancet. 2009;  373 (9677) 1808-1817
• 3 Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets.  Diabetologia. 2002;  45 749-763
• 4 Carlsson PO, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site.  Diabetes. 2001;  50 489-495
• 5 Vajkoczy P, Menger MD, Simpson E, Messmer K. Angiogenesis and vascularization of murine pancreatic islet isografts.  Transplantation. 1995;  60 123-127
• 6 Hirshberg B, Mog S, Patterson N, Leconte J, Harlan DM. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.  J Clin Endocrinol Metab. 2002;  87 5424-5429
• 7 Mattsson G, Jansson L, Carlsson PO. Decreased vascular density in mouse pancreatic islets after transplantation.  Diabetes. 2002;  51 1362-1366
• 8 Mattsson G, Jansson L, Nordin A, Andersson A, Carlsson PO. Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver.  Diabetes. 2004;  53 948-954
• 9 Lehmann R, Zuellig RA, Kugelmeier P, Baenninger PB, Moritz W, Perren A, Clavien PA, Weber M, Spinas GA. Superiority of small islets in human islet transplantation.  Diabetes. 2007;  56 594-603
• 10 O’Sullivan ES, Johnson AS, Omer A, Hollister-Lock J, Bonner-Weir S, Colton CK, Weir GC. Rat islet cell aggregates are superior to islets for transplantation in microcapsules.  Diabetologia. 2010;  53 937-945
• 11 Lau J, Henriksnas J, Svensson J, Carlsson PO. Oxygenation of islets and its role in transplantation.  Curr Opin Organ Transplant. 2009;  14 688-693
• 12 Bennet W, Sundberg B, Groth CG, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG, Elgue G, Larsson R, Nilsson B, Korsgren O. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?.  Diabetes. 1999;  48 1907-1914
• 13 Brandhorst D, Iken M, Tanioka Y, Brendel MD, Bretzel RG, Brandhorst H. Influence of collagenase loading on long-term preservation of pig pancreas by the 2-layer method for subsequent islet isolation.  Transplantation. 2005;  79 38-43
• 14 Papas KK, Pisania A, Wu H, Weir GC, Colton CK. A stirred microchamber for oxygen consumption rate measurements with pancreatic islets.  Biotechnol Bioeng. 2007;  98 1071-1082

Correspondence